Pfizer Inc. / PFE

Дата на съобщението : 22.03.2022 18:27
Тип на съобщението : Замяна на изпратено по-рано съобщение
ISIN : US7170811035
Тип на събитието : Годишно общо събрание
Описание на събитието : Свикване на годишно общо събрание на акционерите.

---

Дата на обявяване на събитието: 17.03.2022 г.
Съобщението се отнася за лицата, вписани като акционери към дата: 02.03.2022 г.
Дата на провеждане на общо събрание: 28.04.2022 г.



Допълнителна информация
Meeting Agenda:
1.1. Elect Director Ronald E. Blaylock (For, Against, Abstain, Do Not Vote)
1.2. Elect Director Albert Bourla (For, Against, Abstain, Do Not Vote)
1.3. Elect Director Susan Desmond Hellmann (For, Against, Abstain, Do Not Vote)
1.4. Elect Director Joseph J. Echevarria (For, Against, Abstain, Do Not Vote)
1.5. Elect Director Scott Gottlieb (For, Against, Abstain, Do Not Vote)
1.6. Elect Director Helen H. Hobbs (For, Against, Abstain, Do Not Vote)
1.7. Elect Director Susan Hockfield (For, Against, Abstain, Do Not Vote)
1.8. Elect Director Dan R. Littman (For, Against, Abstain, Do Not Vote)
1.9. Elect Director Shantanu Narayen (For, Against, Abstain, Do Not Vote)
1.10. Elect Director Suzanne Nora Johnson (For, Against, Abstain, Do Not Vote)
1.11. Elect Director James Quincey (For, Against, Abstain, Do Not Vote)
1.12. Elect Director James C. Smith (For, Against, Abstain, Do Not Vote)
2. Ratify KPMG LLP as Auditors (For , Against, Abstain, Do Not Vote)
3. Advisory Vote to Ratify Named Executive Officers' Compensation (For, Against, Abstain, Do Not Vote)
4. Amend Proxy Access Right (For, Against, Abstain, Do Not Vote)
5. Report on Congruency of Political Electioneering Expenditures with Company Values and Policies (For, Against, Abstain , Do Not Vote)
6. Report on Feasibility of Technology Transfer to Boost Covid 19 Vaccine Production (For, Against , Abstain, Do Not Vote)
7. Report on Board Oversight of Risks Related to Anticompetitive Practices (For, Against, Abstain, Do Not Vote)
8. Report on Public Health Costs of Limited Sharing of Vaccine Technology (For, Against, Abstain, Do Not Vote)
Blocking: No Country: US Partial Vote: Yes Split Vote: Yes
ALERT:
Please be informed this meeting was regressed to change the code of item 7 from S0429 to S0729 Report on Board Oversight of Risks Related to Anticompetitive Practices
ALERT:
TO VOTE THROUGH CLEARSTREAM SEND AN ELECTRONIC INSTRUCTION VIA XACT/SWIFT. TO ATTEND THE MEETING IN PERSON SEND AN ELECTRONIC INSTRUCTION VIA XACT/SWIFT AND INCLUDE THE FOLLOWING ATTENDEE DETAILS(colon)
FULL NAME, FULL ADDRESS, PASSPORT NUMBER, DATE OF BIRTH, PHONE NUMBER. FAILURE TO PROVIDE CLEARSTREAM WITH THE REQUIRED INFORMATION WILL RESULT IN THE REJECTION OF YOUR INSTRUCTION. FOR INQUIRIES PLEASE CONTACT YOUR REGULAR CUSTOMER SUPPORT TEAM. ATTENTION: SECURITIES ADM/CORPORATE ACTIONS/REORG FOR INQUIRIES PLEASE CONTACT YOUR REGULAR CUSTOMER SUPPORT TEAM PLEASE FIND FURTHER INFORMATION ABOUT DATA PROTECTION ON OUR WEBSITE: https://www.clearstream.com/clearst ream-en/about-clearstream/due-dilig ence/gdpr/dataprotection